Q3 25 EPS
$0.33
BEAT +13.79%
Est. $0.29
Q3 25 Revenue
$276.9M
BEAT +5.73%
Est. $261.9M
vs S&P Since Q3 25
+26.9%
BEATING MARKET
CGNX +34.8% vs S&P +7.9%
Market Reaction
Did CGNX Beat Earnings? Q3 2025 Results
Cognex delivered a standout Q3 2025, posting adjusted diluted EPS of $0.33 against a consensus estimate of $0.29, a 13.56% beat, while revenue climbed 18.0% year over year to $276.89 million, topping the $261.89 million consensus by 5.73%. The primar… Read more Cognex delivered a standout Q3 2025, posting adjusted diluted EPS of $0.33 against a consensus estimate of $0.29, a 13.56% beat, while revenue climbed 18.0% year over year to $276.89 million, topping the $261.89 million consensus by 5.73%. The primary engine behind the quarter was broad-based momentum across Logistics and Factory Automation, with Consumer Electronics and Packaging contributing meaningfully, alongside a one-time benefit from a commercial partnership with a medical lab automation channel partner. Operating margin expanded 750 basis points to 20.9%, and adjusted EBITDA margin reached 24.9%, the highest level since Q2 2023. Cash generation was equally compelling, with free cash flow rising 66% to $86.03 million. Institutional investors have taken note, with several funds boosting their CGNX positions ahead of the print. Looking ahead, Cognex guided Q4 2025 revenue of $230 million to $245 million, representing roughly 3% year-over-year growth at the midpoint, with adjusted EPS of $0.19 to $0.24, as the company continues to see no material tariff impact on earnings, a reassuring contrast for semiconductor peers navigating similar pressures.
Key Takeaways
- • Revenue growth driven by Logistics and strength in broader Factory Automation, particularly Consumer Electronics and Packaging
- • One-time benefit from commercial partnership with a medical lab automation channel partner contributed approximately $13 million in incremental revenue
- • Disciplined cost management drove adjusted operating expenses flat year over year; declined 2% on constant-currency basis
- • Operating margin expanded 750 basis points year over year to 20.9%
- • Adjusted EBITDA margin of 24.9% was highest level since Q2 2023
- • Adjusted diluted EPS growth of 69% year over year, fifth consecutive quarter of growth
CGNX YoY Financials
Q3 2025 vs Q3 2024, source: SEC Filings
“I'm pleased to report Q3 was another strong quarter for Cognex. We delivered outstanding financial results, which reflect our commitment to profitable growth and disciplined execution. At the same time, we remain focused on advancing our strategic objective: to be the leading provider of AI technology for industrial machine vision. Additionally, we continued to execute our salesforce transformation, acquiring new customers in underpenetrated verticals such as Packaging, using our easy-to-use, AI-enabled products.”
— Matt Moschner, Q3 2025 Earnings Press Release
CGNX Earnings Trends
CGNX vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CGNX EPS Trend
Earnings per share: estimate vs actual
CGNX Revenue Trend
Quarterly revenue: estimate vs actual
CGNX Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $0.25 | $0.34 | +36.00% | $268.4M | +9.10% |
| Q4 25 BEAT FY | $0.22 | $0.27 | +22.73% | $252.3M | +5.80% |
| FY Full Year | $0.96 | $1.02 | +6.00% | $994.4M | +1.41% |
| Q3 25 BEAT | $0.29 | $0.33 | +13.79% | $276.9M | +5.73% |
| Q2 25 BEAT | $0.23 | $0.24 | +4.35% | $249.1M | +1.21% |
| Q1 25 BEAT | $0.13 | $0.16 | +23.08% | $216.0M | +1.77% |